Screening of BRCA1/2 variants in Mauritanian breast cancer patients

BMC Cancer. 2022 Jul 20;22(1):802. doi: 10.1186/s12885-022-09903-8.

Abstract

Background and study aim: Carrying a pathogenic BRCA1/2 variant increases greatly young women's risk of developing breast cancer (BC). This study aimed to provide the first genetic data on BC in Mauritania.

Methods: Using NGS based screening; we searched for BRCA1/2 variants in DNA samples from 137 patients diagnosed for hereditary BC.

Results: We identified 16 pathogenic or likely pathogenic (PV) variants carried by 38 patients. Two predominant BRCA1 PV variants were found: c.815_824dup and c.4986 + 6 T > C in 13 and 7 patients, respectively. Interestingly, three novels BRCA1/2 predicted pathogenic variants have also been detected. Notably, no specific distribution of BRCA1/2 variants was observed regarding triple negative breast cancer (TNBC) or patient gender status.

Conclusions: In this first genetic profiling of BC in Mauritania, we identified a substantial number of BRCA1/2 pathogenic variants. This finding could be important in the future diagnosis and prevention policy of hereditary BC in Mauritania.

Keywords: BRCA1/2; Breast cancer (BC); Mauritania; Variant; Women.

MeSH terms

  • BRCA1 Protein / genetics
  • BRCA2 Protein / genetics*
  • Breast Neoplasms* / epidemiology
  • Breast Neoplasms* / genetics
  • Early Detection of Cancer
  • Female
  • Genetic Predisposition to Disease
  • Germ-Line Mutation
  • Humans
  • Mauritania / epidemiology
  • Triple Negative Breast Neoplasms*

Substances

  • BRCA1 Protein
  • BRCA1 protein, human
  • BRCA2 Protein
  • BRCA2 protein, human

Supplementary concepts

  • Breast Cancer, Familial